نتائج البحث - "Yun Ju Bae"

1

دورية أكاديمية

Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

المصدر: Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)

مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1752-8054; https://doaj.org/toc/1752-8062

URL الوصول: https://doaj.org/article/7d507bd001904a1aa34884f6d604a326

View record at Wiley

Find this article in full text from ProQuest

Full Text Finder

2

دورية أكاديمية

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

المؤلفون: Jonathan Kay, Janusz Jaworski, Rafal Wojciechowski, Piotr Wiland, Anna Dudek, Marek Krogulec, Slawomir Jeka, Agnieszka Zielinska, Jakub Trefler, Katarzyna Bartnicka-Maslowska, Magdalena Krajewska-Wlodarczyk, Piotr A. Klimiuk, Sang Joon Lee, Yun Ju Bae, Go Eun Yang, Jae Kyoung Yoo, Daniel E. Furst, Edward Keystone

المصدر: Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)

مصطلحات موضوعية: Adalimumab, Biologics, Biosimilars, Comparative effectiveness, Immunogenicity, Monoclonal antibodies, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1478-6362

URL الوصول: https://doaj.org/article/6b49e98734e7429687859127a57bc3fa

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

3

Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

المصدر: Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)
Clinical and Translational Science

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Injections, Subcutaneous, Cmax, Urology, RM1-950, General Biochemistry, Genetics and Molecular Biology, Article, Subcutaneous injection, Young Adult, Pharmacokinetics, Double-Blind Method, Republic of Korea, Adalimumab, medicine, Humans, General Pharmacology, Toxicology and Pharmaceutics, skin and connective tissue diseases, Equivalence (measure theory), Biosimilar Pharmaceuticals, business.industry, General Neuroscience, Immunogenicity, Research, Healthy subjects, General Medicine, Articles, Middle Aged, Confidence interval, Healthy Volunteers, humanities, Therapeutic Equivalency, Area Under Curve, Female, Tumor Necrosis Factor Inhibitors, Therapeutics. Pharmacology, Public aspects of medicine, RA1-1270, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0bf9cbad8bbb9778d884d99b5281e7
https://doaj.org/article/7d507bd001904a1aa34884f6d604a326

View record at Wiley

Find this article in full text from ProQuest

4

Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects

المؤلفون: Eun Jin Choi, Darin Brimhall, Jonathan Kay, Antonia Davidson, Yun Ju Bae, Sung Hyun Kim, Edward C. Keystone, Sang Joon Lee, Daniel E. Furst

المصدر: British Journal of Clinical Pharmacology

مصطلحات موضوعية: medicine.medical_specialty, viruses, Cmax, Urology, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, immune system diseases, Autoinjector, Adalimumab, medicine, Clinical endpoint, Humans, Pharmacology (medical), 030212 general & internal medicine, Biosimilar Pharmaceuticals, Equivalence (measure theory), Pharmacology, business.industry, Syringes, virus diseases, Biosimilar, Original Articles, phase I, Healthy Volunteers, Confidence interval, Therapeutic Equivalency, biologicals, Area Under Curve, drug delivery, Original Article, monoclonal antibodies, Tomography, X-Ray Computed, business, pharmacokinetics, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4eaead76253169e4699828e594f138
https://doi.org/10.1111/bcp.14850

View record at Wiley

5

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019

المصدر: Open forum infectious diseases. 9(8)

مصطلحات موضوعية: Infectious Diseases, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2c70fe57856b67903bcb46c204a57d
https://pubmed.ncbi.nlm.nih.gov/36043180

6

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

المصدر: Rheumatology (Oxford, England)

مصطلحات موضوعية: rheumatoid arthritis, Adult, Male, medicine.medical_specialty, DMARDs (biologic), Arthritis, Rheumatoid, Antibodies, Monoclonal, Murine-Derived, 03 medical and health sciences, rituximab, 0302 clinical medicine, Double-Blind Method, Rheumatology, Quality of life, Internal medicine, medicine, Humans, Pharmacology (medical), skin and connective tissue diseases, Biosimilar Pharmaceuticals, 030203 arthritis & rheumatology, Response rate (survey), B cells, Drug Substitution, business.industry, Surrogate endpoint, Immunogenicity, anti-TNF, Clinical Science, Middle Aged, medicine.disease, switch, United States, Europe, Treatment Outcome, Antirheumatic Agents, 030220 oncology & carcinogenesis, Pharmacodynamics, Rheumatoid arthritis, Quality of Life, Female, Rituximab, biosimilar, business, CT-P10, disease activity, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650450e531d93732fb56232203629d15
https://doi.org/10.1093/rheumatology/kez152

7

Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis

المؤلفون: Sung Hyun Kim, Go Eun Yang, Marek Krogulec, Janusz Jaworski, Sang Joon Lee, Jonathan Kay, Anna Dudek, Edward C. Keystone, Yun Ju Bae, Jae Kyoung Yoo, Piotr Adrian Klimiuk, Piotr Wiland, Rafał Wojciechowski, Daniel E. Furst, Sławomir Jeka, Magdalena Krajewska-Włodarczyk, Jakub Trefler, Agnieszka Zielińska, Katarzyna Bartnicka-Maslowska

المصدر: Rheumatology (Oxford, England). 61(4)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc903606c0634f5a88282630baf45975
https://pubmed.ncbi.nlm.nih.gov/34559204

8

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

المؤلفون: Katarzyna Bartnicka-Maslowska, Jae Kyoung Yoo, Piotr Wiland, Magdalena Krajewska-Włodarczyk, Jakub Trefler, Yun Ju Bae, Jonathan Kay, Agnieszka Zielińska, Go Eun Yang, Janusz Jaworski, Sławomir Jeka, Daniel E. Furst, Rafał Wojciechowski, Sang Joon Lee, Anna Dudek, Marek Krogulec, Edward C. Keystone, Piotr Adrian Klimiuk

المصدر: Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Arthritis Research & Therapy

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Population, Biologics, law.invention, Arthritis, Rheumatoid, Double-Blind Method, Randomized controlled trial, Pharmacokinetics, law, Internal medicine, Clinical endpoint, Adalimumab, medicine, Humans, Rheumatoid arthritis, skin and connective tissue diseases, education, Biosimilar Pharmaceuticals, Biosimilars, education.field_of_study, business.industry, medicine.disease, Tumor necrosis factor inhibitors, Immunogenicity, Comparative effectiveness, Confidence interval, Rheumatology, Treatment Outcome, Antirheumatic Agents, Monoclonal antibodies, Safety, lcsh:RC925-935, Tomography, X-Ray Computed, business, Research Article, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cabcce7cfdd984768e84738fd71a94c
https://doi.org/10.1186/s13075-020-02394-7

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

9

دورية أكاديمية

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY.

المؤلفون: Danese, Silvio, Colombel, Jean-Frederic, Hanauer, Stephen, Sandborn, William, Sands, Bruce, Schreiber, Stefan, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Si Young Yang, Jimin Lee, Ga Hee Park, Ju Hyun Lee

المصدر: Inflammatory Bowel Diseases; 2024 Supplement, Vol. 30, pS9-S10, 2p

View record in Lippincott, Williams & Wilkins

Full Text Finder

10

دورية أكاديمية

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS - POST HOC ANALYSIS OF LIBERTY-CD AND LIBERTY-UC STUDY.

المؤلفون: Schreiber, Stefan, Colombel, Jean-Frederic, Hanauer, Stephen, Sandborn, William, Sands, Bruce, Danese, Silvio, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Si Young Yang, Jimin Lee, Ga Hee Park, Ju Hyun Lee

المصدر: Inflammatory Bowel Diseases; 2024 Supplement, Vol. 30, pS8-S9, 2p

View record in Lippincott, Williams & Wilkins

Full Text Finder

تنقيح النتائج